Wg. Mayhan et Gm. Sharpe, EFFECT OF CIGARETTE-SMOKE EXTRACT ON ARTERIOLAR DILATATION IN-VIVO, Journal of applied physiology, 81(5), 1996, pp. 1996-2003
The goal of this study was to determine whether cigarette smoke extrac
t alters dilatation of arterioles in vivo in response to agonists that
produce activation of ATP-sensitive potassium channels and activation
of adenylate cyclase. By using intravital microscopy, we measured dia
meter of arterioles contained within the microcirculation of the hamst
er cheek pouch during suffusion with agonists in the absence and prese
nce of cigarette smoke extract (0.1, 0.5, and 1.0%). Before treatment
with cigarette smoke extract, activation of ATP-sensitive potassium ch
annels with aprikalim and cromakalim produced dose-related dilatation
of cheek pouch arterioles, Similarly, activation of adenylate cyclase
with isoproterenol and forskolin produced dose-related dilatation of c
heek pouch arterioles before treatment with cigarette smoke extract. S
uperfusion of 0.1% cigarette smoke extract did not change baseline dia
meter of arterioles and did not alter responses of cheek pouch arterio
les to activation of ATP-sensitive potassium channels and adenylate cy
clase. Superfusion of 0.5 and 1.0% cigarette smoke extract also did no
t alter baseline diameter of arterioles but did impair dilatation of a
rterioles in response to activation of ATP-sensitive potassium channel
s and adenylate cyclase. These findings suggest that cigarette smoke e
xtract impairs dilatation of resistance arterioles in response to acti
vation of important cellular dilator pathways.